CA3104520A1 - Positron emission tomography (pet) radiotracers for imaging macrophage colony-stimulating factor 1 receptor (csf1r) in neuroinflammation - Google Patents
Positron emission tomography (pet) radiotracers for imaging macrophage colony-stimulating factor 1 receptor (csf1r) in neuroinflammation Download PDFInfo
- Publication number
- CA3104520A1 CA3104520A1 CA3104520A CA3104520A CA3104520A1 CA 3104520 A1 CA3104520 A1 CA 3104520A1 CA 3104520 A CA3104520 A CA 3104520A CA 3104520 A CA3104520 A CA 3104520A CA 3104520 A1 CA3104520 A1 CA 3104520A1
- Authority
- CA
- Canada
- Prior art keywords
- substituted
- group
- alkyl
- unsubstituted
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nuclear Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862689958P | 2018-06-26 | 2018-06-26 | |
| US62/689,958 | 2018-06-26 | ||
| PCT/US2019/039234 WO2020006075A1 (en) | 2018-06-26 | 2019-06-26 | Positron emission tomography (pet) radiotracers for imaging macrophage colony-stimulating factor 1 receptor (csf1r) in neuroinflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3104520A1 true CA3104520A1 (en) | 2020-01-02 |
Family
ID=68985080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3104520A Pending CA3104520A1 (en) | 2018-06-26 | 2019-06-26 | Positron emission tomography (pet) radiotracers for imaging macrophage colony-stimulating factor 1 receptor (csf1r) in neuroinflammation |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210290784A1 (https=) |
| EP (1) | EP3813890A4 (https=) |
| JP (2) | JP2021533087A (https=) |
| KR (1) | KR20210013769A (https=) |
| CN (2) | CN118743770A (https=) |
| AU (1) | AU2019294699B2 (https=) |
| BR (1) | BR112020026602A2 (https=) |
| CA (1) | CA3104520A1 (https=) |
| EA (1) | EA202092843A1 (https=) |
| IL (1) | IL279768B2 (https=) |
| MX (1) | MX2021000141A (https=) |
| WO (1) | WO2020006075A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020132651A1 (en) | 2018-12-20 | 2020-06-25 | Amgen Inc. | Kif18a inhibitors |
| EP3898616B1 (en) | 2018-12-20 | 2024-10-02 | Amgen Inc. | Heteroaryl amides useful as kif18a inhibitors |
| JP7676308B2 (ja) * | 2018-12-20 | 2025-05-14 | アムジエン・インコーポレーテツド | Ｋｉｆ１８ａ阻害剤として有用なヘテロアリールアミド |
| US12540129B2 (en) | 2019-08-02 | 2026-02-03 | Amgen Inc. | KIF18A inhibitors |
| WO2021026099A1 (en) | 2019-08-02 | 2021-02-11 | Amgen Inc. | Kif18a inhibitors |
| EP4269404A4 (en) * | 2020-12-25 | 2024-12-04 | Xizang Haisco Pharmaceutical Co., Ltd. | KETOHEXOKINASE INHIBITORS AND USE THEREOF |
| CA3221884A1 (en) * | 2021-06-11 | 2022-12-15 | Norman Lafrance | Expert scoring system for measurement of severity, treatment response and prognosis of peripheral arterial disease |
| AU2024214768A1 (en) * | 2023-01-30 | 2025-08-07 | The Johns Hopkins University | 18 f-labeled pet radiotracers for imaging macrophage colony stimulating factor 1 receptor |
| CN118027009B (zh) * | 2024-04-15 | 2024-07-12 | 北京师范大学 | 一类靶向于csf1r激酶的苯基酰胺类化合物及其应用 |
| CN119498255B (zh) * | 2024-10-24 | 2025-11-25 | 香港理工大学深圳研究院 | 一种抑郁症小鼠模型及其构建方法与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006047504A1 (en) * | 2004-10-22 | 2006-05-04 | Janssen Pharmaceutica, N.V. | Aromatic amides as inhibitors of c-fms kinase |
| CN109069666B (zh) * | 2016-04-29 | 2023-04-04 | 纪念斯隆凯特琳癌症中心 | 使靶向颗粒穿透、分布和响应于恶性脑肿瘤中的组合物和方法 |
-
2019
- 2019-06-26 CN CN202410732670.6A patent/CN118743770A/zh active Pending
- 2019-06-26 WO PCT/US2019/039234 patent/WO2020006075A1/en not_active Ceased
- 2019-06-26 AU AU2019294699A patent/AU2019294699B2/en active Active
- 2019-06-26 EA EA202092843A patent/EA202092843A1/ru unknown
- 2019-06-26 MX MX2021000141A patent/MX2021000141A/es unknown
- 2019-06-26 CA CA3104520A patent/CA3104520A1/en active Pending
- 2019-06-26 US US17/253,336 patent/US20210290784A1/en active Pending
- 2019-06-26 EP EP19825817.0A patent/EP3813890A4/en active Pending
- 2019-06-26 CN CN201980056945.6A patent/CN112638431A/zh active Pending
- 2019-06-26 BR BR112020026602-7A patent/BR112020026602A2/pt unknown
- 2019-06-26 JP JP2020571842A patent/JP2021533087A/ja active Pending
- 2019-06-26 KR KR1020217002632A patent/KR20210013769A/ko not_active Ceased
- 2019-06-26 IL IL279768A patent/IL279768B2/en unknown
-
2024
- 2024-06-13 JP JP2024096077A patent/JP2024133496A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020006075A1 (en) | 2020-01-02 |
| EP3813890A4 (en) | 2022-03-23 |
| MX2021000141A (es) | 2021-03-25 |
| KR20210013769A (ko) | 2021-02-05 |
| AU2019294699A1 (en) | 2021-01-21 |
| CN118743770A (zh) | 2024-10-08 |
| IL279768A (en) | 2021-03-01 |
| EP3813890A1 (en) | 2021-05-05 |
| IL279768B2 (en) | 2025-04-01 |
| US20210290784A1 (en) | 2021-09-23 |
| AU2019294699B2 (en) | 2025-05-01 |
| JP2024133496A (ja) | 2024-10-02 |
| EA202092843A1 (ru) | 2021-04-19 |
| JP2021533087A (ja) | 2021-12-02 |
| CN112638431A (zh) | 2021-04-09 |
| IL279768B1 (en) | 2024-12-01 |
| BR112020026602A2 (pt) | 2021-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3104520A1 (en) | Positron emission tomography (pet) radiotracers for imaging macrophage colony-stimulating factor 1 receptor (csf1r) in neuroinflammation | |
| JP2026021351A (ja) | 前立腺がんの内部放射線療法のための前立腺特異的膜抗原を標的とした高親和性薬剤 | |
| KR102531494B1 (ko) | 탄산 탈수효소 ix를 표적으로 하는 핵 영상화 및 방사선치료 제제 및 이의 용도 | |
| WO2016196628A1 (en) | Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase ix and uses thereof | |
| HK40117453A (zh) | 用於对神经炎症中的巨噬细胞集落刺激因子1受体(csf1r)进行成像的正电子发射断层成像术(pet)放射性示踪剂 | |
| US10912850B2 (en) | 18F-FNDP for pet imaging of soluble epoxide hydrolase (sEH) | |
| HK40006359B (en) | Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase ix and uses thereof | |
| HK40006359A (en) | Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase ix and uses thereof | |
| HK1259764B (en) | Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20241029 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241029 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20241104 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250407 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250430 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250620 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250620 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250702 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20251031 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20260113 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20260113 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260113 |